Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 Next Generation Cancer Diagnostic Devices Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance
  • 2.1.1 Product Type Market Performance (Volume)
  • 2.1.2 Product Type Market Performance (Value)
• 2.2 China Next Generation Cancer Diagnostic Devices Market Performance
• 2.3 USA Next Generation Cancer Diagnostic Devices Market Performance
• 2.4 Europe Next Generation Cancer Diagnostic Devices Market Performance
• 2.5 Japan Next Generation Cancer Diagnostic Devices Market Performance
• 2.6 Korea Next Generation Cancer Diagnostic Devices Market Performance
• 2.7 India Next Generation Cancer Diagnostic Devices Market Performance
• 2.8 Southeast Asia Next Generation Cancer Diagnostic Devices Market Performance
• 2.9 South America Next Generation Cancer Diagnostic Devices Market Performance

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
• 3.2 China Next Generation Cancer Diagnostic Devices Market Performance (Volume)
• 3.3 USA Next Generation Cancer Diagnostic Devices Market Performance (Volume)
• 3.4 Europe Next Generation Cancer Diagnostic Devices Market Performance (Volume)
• 3.5 Japan Next Generation Cancer Diagnostic Devices Market Performance (Volume)
• 3.6 Korea Next Generation Cancer Diagnostic Devices Market Performance (Volume)
• 3.7 India Next Generation Cancer Diagnostic Devices Market Performance (Volume)
• 3.8 Southeast Asia Next Generation Cancer Diagnostic Devices Market Performance (Volume)
• 3.9 South America Next Generation Cancer Diagnostic Devices Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 Roche Holding Ltd.(Switzerland)
  • 4.1.1 Roche Holding Ltd.(Switzerland) Profiles
  • 4.1.2 Roche Holding Ltd.(Switzerland) Product Information
  • 4.1.3 Roche Holding Ltd.(Switzerland) Next Generation Cancer Diagnostic Devices Business Performance
  • 4.1.4 Roche Holding Ltd.(Switzerland) Next Generation Cancer Diagnostic Devices Business Development and Market Status
• 4.2 Abbott Laboratories(US)
  • 4.2.1 Abbott Laboratories(US) Profiles
  • 4.2.2 Abbott Laboratories(US) Product Information
  • 4.2.3 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Business Performance
  • 4.2.4 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Business Development and Market Status
• 4.3 Siemens Healthcare(Germany)
  • 4.3.1 Siemens Healthcare(Germany) Profiles
  • 4.3.2 Siemens Healthcare(Germany) Product Information
  • 4.3.3 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Business Performance
  • 4.3.4 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Business Development and Market Status
• 4.4 Agilent Technologies Inc(Germany)
  • 4.4.1 Agilent Technologies Inc(Germany) Profiles
  • 4.4.2 Agilent Technologies Inc(Germany) Product Information
  • 4.4.3 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Business Performance
  • 4.4.4 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Business Development and Market Status
• 4.5 Illumina Inc.(US)
  • 4.5.1 Illumina Inc.(US) Profiles
  • 4.5.2 Illumina Inc.(US) Product Information
  • 4.5.3 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Business Performance
  • 4.5.4 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Business Development and Market Status
• 4.6 Becton Dickinson and Co.(US)
  • 4.6.1 Becton Dickinson and Co.(US) Profiles
  • 4.6.2 Becton Dickinson and Co.(US) Product Information
  • 4.6.3 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Business Performance
  • 4.6.4 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Business Development and Market Status
• 4.7 QIAGEN N.V.(Germany)
  • 4.7.1 QIAGEN N.V.(Germany) Profiles
  • 4.7.2 QIAGEN N.V.(Germany) Product Information
  • 4.7.3 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Business Performance
  • 4.7.4 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Business Development and Market Status
• 4.8 Affymetrix Inc.(US)
  • 4.8.1 Affymetrix Inc.(US) Profiles
  • 4.8.2 Affymetrix Inc.(US) Product Information
  • 4.8.3 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Business Performance
  • 4.8.4 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Business Development and Market Status
• 4.9 Johnson & Johnson(US)
  • 4.9.1 Johnson & Johnson(US) Profiles
  • 4.9.2 Johnson & Johnson(US) Product Information
  • 4.9.3 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Business Performance
  • 4.9.4 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Business Development and Market Status
• 4.10 Thermo Fisher Scientific Inc.(US)
  • 4.10.1 Thermo Fisher Scientific Inc.(US) Profiles
  • 4.10.2 Thermo Fisher Scientific Inc.(US) Product Information
  • 4.10.3 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Business Performance
  • 4.10.4 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Business Development and Market Status
• 4.11 GE Healthcare(England)
• 4.12 Life Technologies Corp.(US)
• 4.13 Siemens Healthcare(Germany)
• 4.14 Agilent Technologies Inc(Germany)
• 4.15 Illumina Inc.(US)
• 4.20 Thermo Fisher Scientific Inc.(US)

5 Market Performance for Manufacturers

• 5.1 Global Next Generation Cancer Diagnostic Devices Production (K Units) and Market Share by Manufacturers 2013-2018
• 5.2 Global Next Generation Cancer Diagnostic Devices Revenue (M USD) and Market Share by Manufacturers 2013-2018
• 5.3 Global Next Generation Cancer Diagnostic Devices Price (USD/Unit) of Manufacturers 2013-2018
• 5.4 Global Next Generation Cancer Diagnostic Devices Gross Margin of Manufacturers 2013-2018
• 5.5 Market Concentration

6 Global Next Generation Cancer Diagnostic Devices Market Performance (Production Point)

• 6.1 Global Next Generation Cancer Diagnostic Devices Production (K Units) and Market Share by Regions 2013-2018
• 6.2 Global Next Generation Cancer Diagnostic Devices Revenue (M USD) and Market Share by Regions 2013-2018
• 6.3 Global Next Generation Cancer Diagnostic Devices Price (USD/Unit) by Regions 2013-2018
• 6.4 Global Next Generation Cancer Diagnostic Devices Gross Margin by Regions 2013-2018

7 Development Trend for Regions (Production Point)

• 7.1 Global Next Generation Cancer Diagnostic Devices Production (K Units), Revenue (&$B$8&) and Growth Rate 2013-2018
• 7.2 China Next Generation Cancer Diagnostic Devices Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.3 USA Next Generation Cancer Diagnostic Devices Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.4 Europe Next Generation Cancer Diagnostic Devices Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.5 Japan Next Generation Cancer Diagnostic Devices Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.6 Korea Next Generation Cancer Diagnostic Devices Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.7 India Next Generation Cancer Diagnostic Devices Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.8 Southeast Asia Next Generation Cancer Diagnostic Devices Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.9 South America Next Generation Cancer Diagnostic Devices Production (K Units), Revenue (M USD) and Growth Rate 2013-2018

8 Global Next Generation Cancer Diagnostic Devices Market Performance (Consumption Point)

• 8.1 Global Next Generation Cancer Diagnostic Devices Consumption and Market Share by Regions 2013-2018
• 8.2 Global Next Generation Cancer Diagnostic Devices Consumption Value and Market Share by Regions 2013-2018
• 8.3 Global Next Generation Cancer Diagnostic Devices Price (USD/Unit) by Regions 2013-2018

9 Development Trend for Regions (Sales Point)

• 9.1 Global Next Generation Cancer Diagnostic Devices Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.2 China Next Generation Cancer Diagnostic Devices Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.3 USA Next Generation Cancer Diagnostic Devices Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.4 Europe Next Generation Cancer Diagnostic Devices Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.5 Japan Next Generation Cancer Diagnostic Devices Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.6 Korea Next Generation Cancer Diagnostic Devices Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.7 India Next Generation Cancer Diagnostic Devices Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.8 Southeast Asia Next Generation Cancer Diagnostic Devices Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.9 South America Next Generation Cancer Diagnostic Devices Sales and Growth, Sales Value and Growth Rate2013-2018

10 Upstream Source, Technology and Cost

• 10.1 Upstream Source
• 10.2 Technology
• 10.3 Cost

11 Channel Analysis

• 11.1 Market Channel
• 11.2 Distributors

12 Consumer Analysis

• 12.1 Biomarker Development Industry
• 12.2 CTC Analysis Industry
• 12.3 Proteomic Analysis Industry
• 12.4 Epigenetic Analysis Industry

13 Market Forecast 2019-2024

• 13.1 Production (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
  • 13.1.1 Global Next Generation Cancer Diagnostic Devices Production (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
  • 13.1.2 Global Next Generation Cancer Diagnostic Devices Production (K Units) and Growth Rate 2019-2024
  • 13.1.3 China Next Generation Cancer Diagnostic Devices Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.4 USA Next Generation Cancer Diagnostic Devices Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.5 Europe Next Generation Cancer Diagnostic Devices Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.6 Japan Next Generation Cancer Diagnostic Devices Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.7 Korea Next Generation Cancer Diagnostic Devices Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.8 India Next Generation Cancer Diagnostic Devices Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.9 Southeast Asia Next Generation Cancer Diagnostic Devices Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.10 South America Next Generation Cancer Diagnostic Devices Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 13.2 Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.1 Global Next Generation Cancer Diagnostic Devices Consumption and Market Share by Regions 2019-2024
  • 13.2.2 Global Next Generation Cancer Diagnostic Devices Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.3 China Next Generation Cancer Diagnostic Devices Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.4 USA Next Generation Cancer Diagnostic Devices Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.5 Europe Next Generation Cancer Diagnostic Devices Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.6 Japan Next Generation Cancer Diagnostic Devices Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.7 Korea Next Generation Cancer Diagnostic Devices Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.8 India Next Generation Cancer Diagnostic Devices Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.9 Southeast Asia Next Generation Cancer Diagnostic Devices Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.10 South America Next Generation Cancer Diagnostic Devices Sales, Sales Value and Growth Rate 2019-2024
• 13.3 Production (K Units), Revenue (M USD) by Types 2019-2024
  • 13.3.1 Overall Market Performance
  • 13.3.2 Next Generation Sequencing Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.3.3 qPCR & Multiplexing Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.3.4 Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR) Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.3.5 Protein Microarrays Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 13.4 Sales by Application 2019-2024
  • 13.4.1 Overall Market Performance
  • 13.4.2 Biomarker Development Sales and and Growth Rate 2019-2024
  • 13.4.3 CTC Analysis Sales and and Growth Rate 2019-2024
  • 13.4.4 Proteomic Analysis Sales and and Growth Rate 2019-2024
  • 13.4.5 Epigenetic Analysis Sales and and Growth Rate 2019-2024
• 13.5 Price (USD/Unit) and Gross Profit
  • 13.5.1 Global Next Generation Cancer Diagnostic Devices Price (USD/Unit) Trend 2019-2024
  • 13.5.2 Global Next Generation Cancer Diagnostic Devices Gross Profit Trend 2019-2024

14 Conclusion

Geographically, global Next Generation Cancer Diagnostic Devices market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Roche Holding Ltd.(Switzerland)
Abbott Laboratories(US)
Siemens Healthcare(Germany)
Agilent Technologies Inc(Germany)
Illumina Inc.(US)
Becton Dickinson and Co.(US)
QIAGEN N.V.(Germany)
Affymetrix Inc.(US)
Johnson & Johnson(US)
Thermo Fisher Scientific Inc.(US)
GE Healthcare(England)
Life Technologies Corp.(US)
Luminex Corp.(US)
Cepheid Inc.(US)
Allegro Diagnostics Corp.(Brazil)

On the basis of product, we research the production, revenue, price, market share and growth rate, primarily split into
Next Generation Sequencing
qPCR & Multiplexing
Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
Protein Microarrays
DNA Microarrays
For the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Next Generation Cancer Diagnostic Devices for each application, including
Biomarker Development
CTC Analysis
Proteomic Analysis
Epigenetic Analysis
Genetic Analysis
DNA Microarrays
Production, consumption, revenue, market share and growth rate are the key targets for Next Generation Cancer Diagnostic Devices from 2013 to 2024 (forecast) in these regions
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America

If you have any special requirements, please let us know and we will offer you the report as you want.